Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
ABSTRACT Multidrug-resistant (MDR) Gram-negative organisms are a burden on the global health care system. The Tigecycline Evaluation and Surveillance Trial (TEST) is an ongoing global study designed to monitor the in vitro activities of tigecycline and a panel of marketed antimicrobials against a ra...
Enregistré dans:
Auteurs principaux: | Anna Giammanco, Cinzia Calà, Teresa Fasciana, Michael J. Dowzicky |
---|---|
Format: | article |
Langue: | EN |
Publié: |
American Society for Microbiology
2017
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/44b8bcb467834faa960df3f1d2d4aa72 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Tigecycline activity against metallo-β-lactamase-producing bacteria
par: Simit Kumar, et autres
Publié: (2013) -
Risk Factors for Tigecycline-Associated Hypofibrinogenemia
par: Liu J, et autres
Publié: (2021) -
Characterization of antimicrobial‐resistant Escherichia coli causing urinary tract infections in dogs: Passive surveillance in Saskatchewan, Canada 2014 to 2018
par: Rachel Courtice, et autres
Publié: (2021) -
Function and Inhibitory Mechanisms of Multidrug Efflux Pumps
par: Kunihiko Nishino, et autres
Publié: (2021) -
Resistance Patterns of Gram-Negative Bacteria Recovered from Clinical Specimens of Intensive Care Patients
par: Farooq Ahmed Wani, et autres
Publié: (2021)